The White House featured billionaire and Joe Biden-supporter Mark Cuban at a healthcare event on Monday, a team-up that could spell trouble for bipartisan priorities due to the billionaire’s recent high-profile defense of Diversity, Equity, and Inclusion (DEI) initiatives that have become toxic with conservatives.
Cuban, who has a pharmaceutical company that claims it is seeking to make medicines more accessible and affordable, spoke during a roundtable discussion focused on pharmacy benefit managers, better known as PBMs, that Biden administration officials argue are “prescription drug middlemen” that should be subject to more transparency in a bid to lower Rx costs.
There is a bipartisan push in Washington, D.C., to implement new restrictions on PBMs, but the involvement of Cuban — who on Monday also revealed he would back Biden for re-election in a face-off against former…
